Glycated Hbg Index and RDW as Prognstic Indicator in Crit... | NCT07057154

Studies
Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients

NCT07057154

Sponsor

Assiut University

Status

Not yet recruiting

Last Update Posted

Jul 9, 2025Actual

Enrollment

97Estimated

Phase

Not provided

Conditions

Critical Ill Patients

Interventions

Hbg and RDW

Countries

Not provided

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jun 2025

Overall Recruitment Status or Expanded Access Status

Not yet recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jul 5, 2025Estimated

Primary Completion Date

Aug 29, 2026Estimated

Completion Date

Dec 2, 2026Estimated

First Submitted Date

May 29, 2025

First Submission Date that Met QC Criteria

Jul 7, 2025

First Posted Date

Jul 9, 2025Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jul 7, 2025

Last Update Posted Date

Jul 9, 2025Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.

Detailed Description

Primary (Main): determine the levels of the GHI And RDW In Critically Ill Patients at Critical and intermediate care units.

b. Secondary (Subsidiary): Evaluate the prognostic significance of these parameters on patient outcomes, such as overall survival, progression-free survival, response to treatment.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

97Estimated

Arms/Interventions Module

Arm Groups

Not provided

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Hbg and RDW	Device	Hbg and RDW as prognstic indicator in critical ill patients

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Glycated Hemoglobin level	Measurement of Hb level in all patients upon ICU admission.	Baseline
Red Cell Distribution Width (RDW)	Measurement of RDW in all patients upon ICU admission.	baseline
Hemoglobin (Hb) Level	Measurement of Hb level in all patients upon ICU admission.	baseline

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

patients admitted to Critical and Intermediate Care Units in Internal Medicine Department after history taking, examination and diagnosis
diabtic Patients 3-animic Patients

Exclusion Criteria:

Patients under 18 years of age
ICU stay < 24 h
patients without HbA1c, FBG, or RDW data or anything's that's affect the HbA1c .

Accepts Healthy Volunteers

Not provided

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

75 Years

Standard Ages

AdultOlder Adult

Study Population

All patients except patients in exculcion critira

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Rania Moukhter Aziz eldeam	Contact	+201022004702		Moukhterrania@gmail.com
Alaa ELdean Abd Elmoniem, Prof	Contact	+201112732730		alaaelmoniem@aun.edu.eg

Overall Officials

Not provided

Locations

Not provided

Label	URL
Related Info	View source
Related Info	View source

IPD Sharing Statement Module

Plan to Share IPD

Yes

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D004909	Erythrocyte Indices

Ancestor Terms

ID	Term
D006403	Hematologic Tests
D019411	Clinical Laboratory Techniques
D019937	Diagnostic Techniques and Procedures
D003933	Diagnosis

Browse Leaves

Not provided

Browse Branches

Not provided